Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro

Chin Med. 2021 Dec 31;16(1):144. doi: 10.1186/s13020-021-00551-x.

Gaofeng Qin^#^{1

2}, Yunfang Dong^#¹, Zhenhong Liu^#^{1

3}, Zhuoyan Gong^{1

4}, Chenyan Gao¹, Mingcui Zheng¹, Meijing Tian¹, Yannan He¹, Liqun Zhong⁵, Pengwen Wang⁶

¹ Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine (BUCM), Haiyuncang No. 5 in Dongcheng District, Beijing, China.
² Binzhou Medical University Hospital, Shandong, China.
³ Institute for Brain Disorders, Beijing University of Chinese Medicine (BUCM), Beijing, China.
⁴ Beijing Prominion Publishing Co. Ltd, Beijing, China.
⁵ Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine (BUCM), Haiyuncang No. 5 in Dongcheng District, Beijing, China. zhongliqun@sina.com.
⁶ Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine (BUCM), Haiyuncang No. 5 in Dongcheng District, Beijing, China. pw_wang@163.com.

^# Contributed equally.

No abstract available

Publication types